Literature DB >> 11279136

Interferon-gamma sensitizes human myeloid leukemia cells to death receptor-mediated apoptosis by a pleiotropic mechanism.

N Varela1, C Munoz-Pinedo, C Ruiz-Ruiz, G Robledo, M Pedroso, A López-Rivas.   

Abstract

The role of interferon (IFN)-gamma as a sensitizing agent in apoptosis induced by ligation of death receptors has been evaluated in human myeloid leukemia cells. Incubation of U937 cells with IFN-gamma sensitized these cells to apoptosis induced by tumor necrosis factor-alpha, agonistic CD95 antibody, and tumor necrosis factor-related apoptosis-inducing ligand. Other human myeloid leukemic cells were also sensitized by IFN-gamma to death receptor-mediated apoptosis. Treatment of U937 cells with IFN-gamma up-regulated the expression of caspase-8 and potently synergized with death receptor ligation in the processing of caspase-8 and BID cleavage. Concomitantly, a marked down-regulation of BCL-2 protein was also observed in cells incubated with IFN-gamma. Furthermore, the caspase-dependent generation of a 23-kDa fragment of BCL-2 protein, the release of cytochrome c from mitochondria and the activation of caspase-9 were also enhanced upon death receptor ligation in IFN-gamma-treated cells. Ectopically expressed Bcl-2 protein inhibited IFN-gamma-induced sensitization to apoptosis. In summary, these results indicate that IFN-gamma sensitizes human myeloid leukemic cells to a death receptor-induced, mitochondria-mediated pathway of apoptosis.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11279136     DOI: 10.1074/jbc.M100815200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  15 in total

1.  Gamma interferon-induced T-cell loss in virulent Mycobacterium avium infection.

Authors:  Manuela Flórido; John E Pearl; Alejandra Solache; Margarida Borges; Laura Haynes; Andrea M Cooper; Rui Appelberg
Journal:  Infect Immun       Date:  2005-06       Impact factor: 3.441

2.  Intratumoral injection of interferon-gamma gene-modified dendritic cells elicits potent antitumor effects: effective induction of tumor-specific CD8+ CTL response.

Authors:  Jianping Pan; Minghui Zhang; Jianli Wang; Qingqing Wang; Dajing Xia; Wenji Sun; Lihuang Zhang; Hai Yu; Xuetao Cao
Journal:  J Cancer Res Clin Oncol       Date:  2005-02-12       Impact factor: 4.553

3.  Myeloid translocation gene CBFA2T3 directs a relapse gene program and determines patient-specific outcomes in AML.

Authors:  Nickolas Steinauer; Chun Guo; Chunfa Huang; Madeline Wong; Yifan Tu; Carl E Freter; Jinsong Zhang
Journal:  Blood Adv       Date:  2019-05-14

4.  Differential requirements for myeloid leukemia IFN-γ conditioning determine graft-versus-leukemia resistance and sensitivity.

Authors:  Catherine Matte-Martone; Jinling Liu; Meng Zhou; Maria Chikina; Douglas R Green; John T Harty; Warren D Shlomchik
Journal:  J Clin Invest       Date:  2017-06-12       Impact factor: 14.808

5.  Mitochondria-dependent and -independent mechanisms in tumour necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis are both regulated by interferon-gamma in human breast tumour cells.

Authors:  Carmen Ruiz-Ruiz; Abelardo López-Rivas
Journal:  Biochem J       Date:  2002-08-01       Impact factor: 3.857

6.  Activated CD4+ T cells enhance radiation effect through the cooperation of interferon-gamma and TNF-alpha.

Authors:  Yixiang Wang; Soroosh Radfar; Hung T Khong
Journal:  BMC Cancer       Date:  2010-02-23       Impact factor: 4.430

7.  HLA-G expression in acute lymphoblastic leukemia: a significant prognostic tumor biomarker.

Authors:  Noura Alkhouly; Iman Shehata; Manal Basyouni Ahmed; Hanan Shehata; Sara Hassan; Tamer Ibrahim
Journal:  Med Oncol       Date:  2013-01-19       Impact factor: 3.064

8.  IFN-gamma acts directly on activated CD4+ T cells during mycobacterial infection to promote apoptosis by inducing components of the intracellular apoptosis machinery and by inducing extracellular proapoptotic signals.

Authors:  Xujian Li; K Kai McKinstry; Susan L Swain; Dyana K Dalton
Journal:  J Immunol       Date:  2007-07-15       Impact factor: 5.422

Review 9.  Therapeutic applications of TRAIL receptor agonists in cancer and beyond.

Authors:  Gustavo P Amarante-Mendes; Thomas S Griffith
Journal:  Pharmacol Ther       Date:  2015-09-05       Impact factor: 12.310

10.  c-Myc partially mediates IFNgamma-induced apoptosis in the primary hepatocyte.

Authors:  C T McCullough; B J Tura; D J Harrison
Journal:  Int J Exp Pathol       Date:  2007-06       Impact factor: 1.925

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.